I was recently queried by the Israeli Life Science Industry on my thoughts regarding trends in the global biotechnology industry as well as elements of specific interest to Israel. You can see my full interview at ILSI’s website.
Home Talks and Publications
Educating the Next Generation of Biotechnology Managers and Founders
I recently gave a talk on educating the next generation of biotechnology managers and founders at a biotechnology education workshop. My sense is that the traditional education paths are not ideal ways to prepare individuals to manage or start biotechnology companies, and I describe cases from Best Practices in Biotechnology Education and courses I have been involved with to illustrate how educational programs can better prepare students for these roles.
I’ve attached a copy of my presentation below.
Educating the Next Generation of Biotechnology Founders and Managers
I will be giving a talk on Educating the Next Generation of Biotechnology Founders and Managers at Pittcon in Orlando on March 1st.
The talk will be based on my observations in writing Building Biotechnology and editing Best Practices in Biotechnology Education, in addition to the teaching I’ve done on the topic. I’ll be posting my slides after the event, but for a preview you can see my recent editorial on continuing education in biotechnology in the Journal of Commercial Biotechnology.
Hope to meet some readers while I’m down there…
How do you train your new biotechnology employees?
I’m giving a talk at Pittcon on biotechnology training this spring. As many readers know, I have been very active in biotechnology education through my books and the classes I teach. So, I’ve got a strong sense of the supply-side of biotechnology education and training, and the academic side of biotechnology education, but would like some more perspective on the industry side of biotechnology education and training.
So, I’d like to post an open question:
How do you train your new biotechnology employees?
I want to learn more about the training systems used to bring new hires, with either scientific or business backgrounds, up to speed on the business of biotechnology. What are the methods and tools you use? You may post your response in the comments below, or if you’d rather be off the record, feel free to contact me directly.
Scientific American worldView Interview available
Moira Gunn’s Tech Nation interview of Jeremy Abbate and I on the Scientific American worldView project is now available at IT Conversations. For more details, you can also see our video interview and the worldView website.
Journal of Commercial Biotechnology — January 2010 issue now available
The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 16, Issue 1
Editorial
| Time for a new business model? | |
| Yali Friedman |
Commentary
| Why data exclusivity is the new patent protection | |
| Peter J Pitts |
| Follow-on biologic drug competition – No need for new marketing exclusivities | |
| Michael S Wroblewski, Elizabeth A Jex |
Articles
| Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb | |
| Nigel Borshell, Adrian Dawkes |
| Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms | |
| Mark J Ahn, Michael Meeks, Sally Davenport, Rebecca Bednarek |
| Intellectual property landscape and patenting opportunity in biofuels | |
| Ramasamy Mannan |
| Challenges and opportunities in the licensing of renewable technologies | |
| Meredith Lloyd-Evans, Mike Gilbert, Ilian P Iliev |
| Ethiopia: Biotechnology for development | |
| Desta Berhe Sbhatu |
| Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy | |
| Olivia Harvey |
Legal and Regulatory Updates
| Using IP audits to optimize IP assets | |
| James G Cullem |
Book Reviews
| Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care services | |
| Frank LaSaracina |
| Book Review: Aging, Biotechnology, and the Future | |
| Harley King |
Kyoto Prize Journalism Fellowship
I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.
This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made outstanding lifetime achievements in technology, science, or the arts. This year’s laureates are:
Dr. Isamu Akasaki, Blue LED pioneer
Drs. Peter and Rosemary Grant, Evolutionary Biologists
Pierre Boulez, World-renowned composer, conductor
I am honored to have the opportunity to attend this prestigious event and to learn more about innovation in diverse disciplines.
Journal of Commercial Biotechnology — October 2009 issue now available
The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 15, Issue 4
Editorial
| Intellectual property and biotechnology innovation: To protect or not protect? | |
| Yali Friedman |
Commentary
| The correlation between medical tourism and biotechnology | |
| David G Vequist IV, Erika Valdez |
| The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview | |
| William Bains |
Articles
| Innovate America: The Technology Innovation Program at NIST | |
| Andrew S Klein, Mrunal S Chapekar |
| Valuation of complex license contracts | |
| Ralph Villiger, Boris Bogdan |
| How can pharmaceutical and biotechnology companies maintain a high profitability? | |
| Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel |
| Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry | |
| J Leslie Glick |
| Building biotechnology teams: Personality does matter | |
| Anne S York, Kim A McCarthy, Todd C Darnold |
| Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement | |
| Rob Hanes, Damon Borich |
Legal and Regulatory Updates
| Legal and Regulatory Update | |
| Gerry Kamstra, John Wilkinson |
Book Reviews
| Book Review: Genomics & society: Legal, ethical and social dimensions | |
| Dominic Clark |
| Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace | |
| Arlen D Meyers |
| Book Review: Biotech funding trends: Insights from entrepreneurs and investors | |
| J Leslie Glick |
The impact of the global financial crisis on biotechnology development
My most recent editorial in the Journal of Commercial Biotechnology, “The impact of the global financial crisis on biotechnology development,” examines the response of governments around the world to their investments in biotechnology and healthcare innovation. It is a theme that I also raised in the Scientific American WorldVIEW. The bottom line is: despite economic hardships, given the direct health and indirect economic benefits of biotechnology research, will governments sustain, increase, or decrease their R&D budgets?
Journal of Commercial Biotechnology — July 2009 issue now available
The July 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 15, Issue 3
Editorial
| The impact of the global financial crisis on biotechnology development | |
| Yali Friedman |
Commentary
| Can genetic engineering prevent food-poisoning? | |
| Henry Miller |
Articles
| Bottom line compliance for biotechnology: Six secrets | |
| John Avellanet |
| Maturation of the biotechnology industry changes job opportunities for scientists | |
| Helen Liu, Molly B Schmid |
| Biotechnology business models: An Indian perspective | |
| Viren Konde |
| Tracking progress: Two approaches to biotechnology development – Cases from Central Europe | |
| Tomasz Mroczkowski, Heather Elms |
| Umbilical cord blood banks: Modern day alchemy | |
| Helen Smith |
| China 10-Point Patent Checklist: Integrating patents into an overall business strategy for a Western manufacturing entity in China | |
| Catherine Sun, Sharon R Barner, Harold C Wegner |
From the Classroom
| Bioscience enterprise: Postgraduate education at Cambridge and Auckland | |
| Linda Allan, Joerg Kistler, Chris Lowe, Wendell Dunn, Claire McGowan, Geoff Whitcher |
Legal and Regulatory Updates
| Legal and regulatory update | |
| John Wilkinson |
Book Reviews
| Book Review: Spin-outs: Creating businesses from university intellectual property | |
| Arlen D Meyers |
| Book Review: Venture capital and the European biotechnology industry | |
| Leonard Lerer |
Prev